INCLUSION BODY MYOSITIS
Clinical trials for INCLUSION BODY MYOSITIS explained in plain language.
Never miss a new study
Get alerted when new INCLUSION BODY MYOSITIS trials appear
Sign up with your email to follow new studies for INCLUSION BODY MYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a transplant drug slow a rare muscle disease?
Disease control OngoingThis phase 3 trial tests sirolimus, a drug used in organ transplants, to see if it can slow or stop muscle decline in people with inclusion body myositis (IBM), a rare muscle disease. About 140 adults aged 45 and older who can walk at least 200 meters are taking part. The study m…
Matched conditions: INCLUSION BODY MYOSITIS
Phase: PHASE3 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 17, 2026 09:27 UTC
-
New test could predict falls in muscle disease patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to create a simple test to predict fall risk in people with neuromuscular disorders like muscular dystrophy, ALS, and myasthenia gravis. Researchers will measure how well participants perform tasks like standing up from a chair, walking, and balancing. The goal is…
Matched conditions: INCLUSION BODY MYOSITIS
Sponsor: LMU Klinikum • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC
-
New study tracks rare muscle disease to uncover its secrets
Knowledge-focused OngoingThis study follows 150 adults with sporadic inclusion body myositis, a rare muscle-weakening disease, for two years. Researchers will measure muscle strength, swallowing, breathing, and blood markers every six months. The goal is to learn how the disease progresses, not to test a…
Matched conditions: INCLUSION BODY MYOSITIS
Sponsor: University of California, Irvine • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC